Predictors of heroin abstinence in opiate substitution therapy in heroin-only users and dual users of heroin and crack
- PMID: 29065377
- DOI: 10.1016/j.addbeh.2017.10.013
Predictors of heroin abstinence in opiate substitution therapy in heroin-only users and dual users of heroin and crack
Abstract
Aims: To analyse predictors of heroin abstinence in opiate substitution therapy (OST) based on frequency of crack use and its interactions with other predictors in a clinical non-experimental setting.
Design: Retrospective study.
Setting: A community drug service in London, UK.
Participants: 325 clients starting OST between 2010 and 2014 (197 methadone and 128 buprenorphine).
Measurements: Logistic regression models (a general model and separate models for methadone and buprenorphine) assessed demographic and clinical data as predictors of heroin abstinence at one year after treatment start (or at the date of transfer to another service).
Findings: For the general model participants choosing methadone were more likely to use heroin at follow up (OR=2.36, 95% CI: 1.40-3.17) as were daily crack users on methadone (OR=2.62, 95% CI: 0.96-7.16). For the methadone model only daily crack use predicted heroin use at follow up (OR=2.62, 95% CI: 0.96-7.16). For buprenorphine, higher amounts of baseline heroin use, lower buprenorphine dose and daily drinking predicted heroin use at follow up (OR=0.85, 95% CI: 0.75-0.95; OR=1.31, 95% CI: 1.06-1.60 and OR=6.04, 95% CI: 1.26-28.92). Both use of cannabis and depression increased likelihood of heroin abstinence for clients not using crack compared to occasional (OR=6.68, 95% CI: 0.37-119.59; OR=106.31, 95% CI: 3.41-3313.30) and daily (OR=57.49 (95% CI: 2.37-1396.46; OR=170.99 (95% CI: 4.61-6339.47) users.
Conclusions: Most of the predictors in the general model were found significant only in the buprenorphine but not in the methadone model, suggesting that a general model has little predictive value. Crack use was a significant predictor of heroin abstinence at follow up in all models, however for buprenorphine only when depression or cannabis use was present. Further research is needed to assess effective treatment approaches for the growing population of dual users.
Keywords: Abstinence; Crack; Dual use; Heroin; Opiate substitution therapy; Predictors.
Copyright © 2017 Elsevier Ltd. All rights reserved.
Similar articles
-
Effectiveness of community treatments for heroin and crack cocaine addiction in England: a prospective, in-treatment cohort study.Lancet. 2009 Oct 10;374(9697):1262-70. doi: 10.1016/S0140-6736(09)61420-3. Epub 2009 Oct 1. Lancet. 2009. PMID: 19800681
-
Desipramine in opioid-dependent cocaine abusers maintained on buprenorphine vs methadone.Arch Gen Psychiatry. 1999 Sep;56(9):812-20. doi: 10.1001/archpsyc.56.9.812. Arch Gen Psychiatry. 1999. PMID: 12884887 Clinical Trial.
-
Medically assisted recovery from opiate dependence within the context of the UK drug strategy: methadone and Suboxone (buprenorphine-naloxone) patients compared.J Subst Abuse Treat. 2013 Jan;44(1):97-102. doi: 10.1016/j.jsat.2012.04.003. Epub 2012 Jun 15. J Subst Abuse Treat. 2013. PMID: 22703715 Clinical Trial.
-
Methadone and buprenorphine maintenance therapies for patients with hepatitis C virus infected after intravenous drug use.Acta Gastroenterol Belg. 2005 Jan-Mar;68(1):81-5. Acta Gastroenterol Belg. 2005. PMID: 15832591 Review.
-
Multimodal drug addiction treatment: a field comparison of methadone and buprenorphine among heroin- and cocaine-dependent patients.J Subst Abuse Treat. 2006 Jul;31(1):3-7. doi: 10.1016/j.jsat.2006.03.007. J Subst Abuse Treat. 2006. PMID: 16814005 Review.
Cited by
-
The relationship between crystal methamphetamine use and methadone retention in a prospective cohort of people who use drugs.Drug Alcohol Depend. 2021 Aug 1;225:108844. doi: 10.1016/j.drugalcdep.2021.108844. Epub 2021 Jun 24. Drug Alcohol Depend. 2021. PMID: 34182377 Free PMC article.
-
Predictors of concurrent heroin use among patients on opioid maintenance treatment in France: a multilevel study over 11 years.Harm Reduct J. 2024 Jan 19;21(1):15. doi: 10.1186/s12954-024-00934-x. Harm Reduct J. 2024. PMID: 38243253 Free PMC article.
-
Stage-of-change Assessment Predicts Short-term Treatment Engagement for Opioid Use Disorder Patients Initiated on Buprenorphine.West J Emerg Med. 2022 Jun 29;23(5):684-692. doi: 10.5811/westjem.2022.3.53197. West J Emerg Med. 2022. PMID: 36205682 Free PMC article.
-
Does cannabis use substitute for opioids? A preliminary exploratory survey in opioid maintenance patients.Eur Arch Psychiatry Clin Neurosci. 2025 Mar;275(2):565-572. doi: 10.1007/s00406-023-01718-3. Epub 2024 Mar 19. Eur Arch Psychiatry Clin Neurosci. 2025. PMID: 38502206
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical